1. Home
  2. XWEL vs VNRX Comparison

XWEL vs VNRX Comparison

Compare XWEL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XWEL

XWELL Inc.

N/A

Current Price

$0.41

Market Cap

5.9M

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.16

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XWEL
VNRX
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.3M
IPO Year
2010
2012

Fundamental Metrics

Financial Performance
Metric
XWEL
VNRX
Price
$0.41
$0.16
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $12.03
AVG Volume (30 Days)
33.3K
★ 1.8M
Earning Date
12-01-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $29,210,000.00
$1,727,384.00
Revenue This Year
N/A
$68.91
Revenue Next Year
N/A
$279.50
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 40.04
52 Week Low
$0.26
$0.13
52 Week High
$2.20
$3.26

Technical Indicators

Market Signals
Indicator
XWEL
VNRX
Relative Strength Index (RSI) 23.65 39.23
Support Level $0.33 $0.15
Resistance Level $0.50 $0.18
Average True Range (ATR) 0.07 0.02
MACD -0.01 0.00
Stochastic Oscillator 31.60 6.14

Price Performance

Historical Comparison
XWEL
VNRX

About XWEL XWELL Inc.

XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: